Delivery Order SPE2DB24D1104-SPE2DB25FYEQ9
- Not listed
- The Defense Logistics Agency (DLA) awarded a $11,671.29 delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5mL, a meningococcal conjugate vaccine. This competitively awarded, firm fixed-price contract contains no set-aside designation and is scheduled for completion by August 12, 2025. Performance will occur at the contractor's location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's substantial...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,659.15 to AmerisourceBergen Drug Corp for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5 mL, a meningococcal vaccine. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 12, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,127.55 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure. Performance is scheduled for completion by September 22, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $320,103.48 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine, with an ultimate completion date of August 7, 2025. This is a firm fixed price, non-set-aside contract with performance to occur at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a $61,593.00 delivery order to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial A-C-Y-W-135-DIP (0.5ML), a meningococcal vaccine product. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and was competitively awarded without any set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $92,818.40 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This competitively awarded, firm fixed-price delivery order was issued on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $4,197.92 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed price delivery order, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a competitively awarded non-set-aside procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $3,818.28 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. The award, issued on June 16, 2025, with an ultimate completion date of June 17, 2025, represents a firm fixed-price contract with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $94,993.90 to AmerisourceBergen Drug Corp for Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a conjugate meningococcal vaccine. The contract was competitively awarded without set-aside restrictions and carries a firm fixed price structure, with performance to be completed by May 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery order from its...
- The Defense Logistics Agency awarded a $152,714.53 delivery order to AmerisourceBergen Drug Corp for Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML vaccine products, with an ultimate completion date of July 28, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYEQ9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,144.90 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 18, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor for federal medical procurement and consistently wins competitively awarded contracts with DLA for a diverse range of pharmaceutical products and medical supplies. The company's portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific vaccine delivery order represents routine pharmaceutical supply execution under the company's expansive prime vendor agreement with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 8/15/25 |